Retail Offer Issue Price

Not for release to US wire services or distribution in the United States

18 January 2022
NZX / ASX Code: EBO
RETAIL OFFER ISSUE PRICE ANNOUNCED
EBOS Group Limited’s (EBOS) up to NZ$105 million (A$100 million
1
) retail offer (Retail Offer) that
was announced on 15 December 2021 closed yesterday, Monday 17 January 2022.
The new shares under the Retail Offer will be issued at the price of NZ$34.50 / A$32.56
2
, which
represents the lower of the price paid under the placement completed on Friday 10 December 2021
(NZ$34.50 per share) and the five-day VWAP of EBOS shares on NZX up to, and including, close of
the Retail Offer.
The allotment of the new shares issued under the Retail Offer is expected to occur on Monday, 24
January 2022, with NZX trading in the new shares expected to commence on the same day and ASX
trading in the new shares expected to commence on Tuesday, 25 January 2022. The new shares will
rank equally with existing EBOS ordinary shares on issue.
A further announcement on the final outcome of the Retail Offer (including treatment of
oversubscriptions, if any) is expected on or before allotment of the new shares.
This release was authorised for lodgement with NZX and ASX by the Chief Executive Officer.
For further information, please contact:

Investor Relations:
Martin Krauskopf
General Manager, M&A and Investor Relations
EBOS Group
martin.krauskopf@ebosgroup.com
+61 3 9918 5555

Media:
New Zealand:
Geoff Senescall
Senescall Akers
+64 21 481 234

Australia:
Patrick Rasmussen
PRX
+61 430 159 690

1
Assumed an AUD NZD exchange rate of 1.0499 as at 8 December 2021. EBOS may decide to accept applications (in whole or in part) that
result in the Retail Offer raising more than NZ$105 million (A$100 million), in its absolute discretion.
2
Reflecting an AUD NZD exchange rate of 1.0595 as reported by the Reserve Bank of Australia as at 4pm AEDT, 17 January 2022.

ABOUT EBOS GROUP
EBOS Group Limited NZBN 9429031998840 (NZX/ASX Code: EBO) is the largest and most diversified
Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical
products. It is also a leading Australasian animal care brand owner, product marketer and
distributor.

NOT FOR RELEASE OR DISTRIBUTION IN THE UNITED STATES
This market release has been prepared for publication in Australia and New Zealand and may not be
released to US wires services or distributed in the United States. This market release does not
constitute an offer to sell, or a solicitation of an offer to buy, any securities in the United States or
any other jurisdiction. The securities referred to in this release have not been, and will not be,
registered under the US Securities Act of 1933 or the securities laws of any state or other jurisdiction
of the United States and, as a result, the securities may not be offered, sold or resold, directly or
indirectly, in the United States or to persons acting for the account or benefit of a person in the
United States (to the extent such persons hold EBOS shares and are acting for the account or benefit
of a person in the United States) except in transactions exempt from, or not subject to, the
registration requirements of the US Securities Act and the applicable securities laws of any state or
other jurisdiction of the United States.
You must not send copies of this announcement or any other material relating to the Retail Offer to
any person in the United States or elsewhere outside Australia and New Zealand.